http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017056844-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c97f90ab12b35b650d5fd039ed7a41a5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-38 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2016-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abcfcaec21313710eabd48e0ede8276f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_688ef8ef1396ef838434f924fdb4cf7d |
| publicationDate | 2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017056844-A1 |
| titleOfInvention | Method for estimating pathological tissue diagnosis result (gleason score) of prostate cancer |
| abstract | The present invention provides a method for obtaining an index value that is used in a pathological tissue diagnosis of prostate cancer, which can be performed at low invasiveness and at low cost. The method according to the present invention is a method for estimating a Gleason score that represents the degree of malignancy of prostate cancer. In the method, the content of a prostate-specific antigen (PSA), which is an antigen having an N-acetylgalactosamine residue at a non-reductive terminal of a sugar chain, in a sample is determined, and it is estimated that the Gleason score is 7 or more when the measurement value is greater than a threshold value, or it is estimated that the Gleason score is 6 or less when the measurement value is smaller than the threshold value. It is preferred that the quantification of the PSA is carried out by a method involving a step of binding a molecule having affinity for a β-N-acetylgalactosamine residue, e.g., Wisteria floribunda agglutinin (WFA), soybean agglutinin (SBA) or Vicia villosa lectin (VVL), or an anti-β-N-acetylgalactosamine antibody to the PSA. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11137403-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020071199-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3550304-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018101327-A1 |
| priorityDate | 2015-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.